Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

por Daar, Shahina, Pathare, Anil, Nick, Hanspeter, Kriemler-Krahn, Ulrike, Hmissi, Abdel, Habr, Dany, Taher, Ali
Publicado 2009

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study

por Taher, Ali, El-Beshlawy, Amal, Elalfy, Mohsen S, Al Zir, Kusai, Daar, Shahina, Habr, Dany, Kriemler-Krahn, Ulrike, Hmissi, Abdel, Al Jefri, Abdullah
Publicado 2009

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies

por Ratner, Paul, Andrews, Charles P., Hampel, Frank C., Martin, Bruce, Mohar, Dale E., Bourrelly, Denis, Danaietash, Parisa, Mangialaio, Sara, Dingemanse, Jasper, Hmissi, Abdel, van Bavel, Jay
Publicado 2017

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y(12) receptor antagonist, in patients with chronic coronary synd...

por Storey, Robert F, Gurbel, Paul A, ten Berg, Jurrien, Bernaud, Corine, Dangas, George D, Frenoux, Jean-Marie, Gorog, Diana A, Hmissi, Abdel, Kunadian, Vijay, James, Stefan K, Tanguay, Jean-Francois, Tran, Henry, Trenk, Dietmar, Ufer, Mike, Van der Harst, Pim, Van't Hof, Arnoud W J, Angiolillo, Dominick J
Publicado 2019